Broadly Neutralizing Antibodies
-
{
- All
- News
'Broadly Neutralizing Antibodies' - 1 News Result(s)
-
New HIV Vaccine Candidate Shows Promise In Early Trials
A new HIV vaccine candidate developed by the Duke Human Vaccine Institute showed promise in a phase 1 trial, generating broadly neutralizing antibodies and strong immune responses in 20 healthy participants.
'Broadly Neutralizing Antibodies' - 1 News Result(s)
-
New HIV Vaccine Candidate Shows Promise In Early Trials
A new HIV vaccine candidate developed by the Duke Human Vaccine Institute showed promise in a phase 1 trial, generating broadly neutralizing antibodies and strong immune responses in 20 healthy participants.
